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Abstract 
Background: Adipose-derived stem/stromal cells (ASCs) isolated from the stromal vascular fraction are a source of 
mesenchymal stem cells that have been shown to be beneficial in many regenerative medicine applications. ASCs are 
an attractive source of stem cells in particular, due to their lack of immunogenicity. This study examines differences 
between mitochondrial bioenergetic profiles of ASCs isolated from adipose tissue of five peri-organ regions: pericar-
dial, thymic, knee, shoulder, and abdomen.
Results: Flow cytometry showed that the majority of each ASC population isolated from the adipose tissue of 12 
donors, with an n = 3 for each tissue type, were positive for MSC markers CD90, CD73, and CD105, and negative for 
hematopoietic markers CD34, CD11B, CD19, and CD45. Bioenergetic profiles were obtained for ASCs with an n = 4 
for each tissue type and graphed together for comparison. Mitochondrial stress tests provided the following meas-
urements: basal respiration rate (measured as oxygen consumption rate [pmol O2/min], ATP production, proton leak, 
maximal respiration, respiratory control ratio, coupling efficiency, and non-mitochondrial respiration. Glycolytic stress 
tests provided the following measurements: basal glycolysis rate (measured as extracellular acidification rate [mpH/
min]), glycolytic capacity, glycolytic reserve, and non-glycolytic acidification.
Conclusions: The main goal of this manuscript was to provide baseline reference values for future experiments and 
to compare bioenergetic potentials of ASCs isolated from adipose tissue harvested from different anatomical loca-
tions. Through an investigation of mitochondrial respiration and glycolysis, it was demonstrated that bioenergetic 
profiles do not significantly differ by region due to depot-dependent and donor-dependent variability. Thus, although 
the physiological function, microenvironment and anatomical harvest site may directly affect the characteristics of 
ASCs isolated from different organ regions, the ultimate utility of ASCs remains independent of the anatomical harvest 
site.
Keywords: Adipose-derived stem/stromal cells, Human adipose tissue, Mitochondrial bioenergetics, Bioenergetic 
profiling, Stromal vascular fraction, Mesenchymal stem cells, Extracellular flux, Tissue engineering
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Background
Adipose-derived stem/stromal cells (ASCs) isolated 
from the stromal vascular fraction (SVF) have long been 
considered an abundant and ideal source of stem cells for 
tissue regeneration and stem cell research. The SVF is 
the densest component of the lipoaspirate obtained from 
liposuction of excess adipose tissue. SVF isolates typically 
contain many components also found in adipose tissue 
including adipocytes, fibroblasts, preadipocytes, tissue 
resident macrophages, and vascular constituents (Baer 
and Geiger 2012; Aronowitz and Ellenhorn 2013; Gimble 
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et  al. 2011). Most importantly, both adipose tissue and 
SVF provide a source of mesenchymal stem cells (MSCs) 
that do not elicit an immunological response, particularly 
if autologous ASCs are used during point-of-care appli-
cations (McIntosh et al. 2009; Pikuła et al. 2013). Of the 
three main sources of MSCs currently used for human 
studies and therapies—bone marrow, umbilical cord 
blood, and adipose tissue—ASCs show important dif-
ferences from bone-marrow derived MSCs in regard to 
harvest and cell yield, despite similarities in morphology 
and phenotype. Therefore, ASCs represent an attractive, 
abundant and readily available cell type for regenerative 
medicine. ASCs have been successfully used in tissue 
and wound regeneration such as sternal reconstruction 
(Khalpey et  al. 2015), cosmetic reconstruction (Koźlik 
and Wójcicki 2014), and chondrogenesis (Mellor et  al. 
2015; Estes et al. 2010). A major reason ASCs have shown 
great promise is that ASCs from the SVF have 50–74% 
of the matrix-forming ability of fibroblasts, which can be 
helpful in wound healing (Shin et al. 2015).
There are a variety of methods of ASC isolation that 
include mechanical, chemical, or non-enzymatic tech-
niques. However, collagenase-based isolation meth-
ods traditionally yield the highest level of cell recovery. 
Mechanical methods have reported cell yields ranging 
from 6250 to 25,000 ASCs/mL of adipose tissue, whereas 
collagenase methods yield 100,000 to 500,000 viable cells/
mL (Aronowitz and Ellenhorn 2013; Shah et  al. 2013; 
Markarian et  al. 2014; Aronowitz et  al. 2015). While 
the use of collagenase-isolated ASCs in patient-specific 
applications may cause injection-related complications 
such as local allergic reaction, infection, or evidence of 
local tissue destruction, clinical studies in 164 patients 
have shown little or no complications related to colla-
genase isolations (Aronowitz et al. 2015).
ASCs all share similar characteristics despite isolation 
protocol (Sachs et  al. 2012), and it has been recognized 
that adipocytes demonstrate significant intrinsic inflam-
matory properties (Omar et al. 2014). Since adipose tis-
sue is a mediator of inflammation and innate immunity, 
its anatomic location plays a defining role in its specific 
metabolic functions (Omar et  al. 2014; Schwartz and 
Yehuda-Shnaidman 2014). The bioenergetic demand 
of cells from various locations is therefore expected to 
vary, in part due to individual physiologic organ func-
tions. Furthermore, the physiological microenvironment 
that supports stem cells in specific anatomic locations 
can regulate how stem cells participate in tissue regen-
eration, maintenance and repair, and may also be donor-
dependent (Via et  al. 2012). We therefore hypothesized 
that bioenergetic demand of adipose tissue will be cor-
related to intrinsic metabolic function and dependent on 
anatomical location. In this study, we compare the bio-
energetic profiles of freshly isolated adipose tissue of the 
SVF obtained from the abdomen (subcutaneous), thy-
mus, pericardium, knee (peri-patellar), and shoulder of 
healthy human patients.
Methods
Primary culture of human adipose‑derived stem cells
ASCs were isolated from freshly excised human subcu-
taneous adipose tissue following methods adapted from 
Estes et al. (2010). Donors (n = 12) were both male and 
female, between 18 and 65 years of age. All samples were 
obtained as surgical discards with approval from the Uni-
versity of Arizona Internal Review Board (IRB approval 
numbers: 01-0770-01 and 1300000194A004) from 
the adipose tissue surrounding the following regions: 
abdominal (subcutaneous), knee (peri-patellar), shoul-
der, pericardium, and thymus. In brief, adipose tissue was 
minced and washed extensively with 1X PBS + 1% antibi-
otic–antimycotic (Thermo Scientific, Waltham, MA), and 
then incubated at 37  °C for 60  min in 2  mg/ml of type 
I collagenase (Worthington Biochemical, Lakewood, NJ, 
USA). Enzyme activity was neutralized with Dulbecco’s 
modified Eagle’s medium–low glucose (DMEM, Gibco, 
Grand Island, NY, USA), containing 10% FBS, and cells 
were centrifuged at 1200 rpm for 10 min to remove adi-
pocytes and filtered through a 100  μm nylon mesh to 
remove debris, and incubated in a culture flask at 37 °C at 
standard cell culture conditions of 95% O2 and 5% CO2. 
Following incubation for 3  days, the cells were washed 
with 1X PBS to remove non-adherent cells. ASCs were 
isolated from adipose of 12 donors, with an n  =  4 for 
each tissue type.
Flow cytometry
Cells extracted from each source were evaluated for mes-
enchymal stem cell markers (CD90, CD105, and CD73), 
hematopoietic cell markers (CD34, CD11B, CD19, and 
CD45), and HLA-DR. Cells were kept between passages 
1–3, and analyzed immediately when the cell number 
required for flow cytometry analysis was achieved in 
culture.
Culture medium was removed and cells were washed 
with 1X PBS. Cells were then detached from the flask 
using BD Accutase Cell Detachment Solution (BD Bio-
sciences, San Jose, CA, Cat #561,527), centrifuged at 
1500 rpm for 5 min, and re-suspended in BD Pharmingen 
stain buffer (BD Biosciences, San Jose, CA, Cat #554656) 
at a concentration of 5 × 106 cells/mL. The cell suspen-
sion was filtered through a 40 μm mesh filter. 100 μL cell 
suspension was added to each tube containing antibod-
ies from the BD Stemflow Human MSC Analysis Kit (BD 
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Biosciences, San Jose, CA, Cat #562245) and are reported 
in Table  1. Antibody/cell mixtures were incubated in 
the dark on ice for 30  min. The tubes were centrifuged 
at 1500  rpm for 5  min, washed twice with 100  μL stain 
buffer, and then re-suspended in 500 μL stain buffer.
Cells were analyzed on a FACSCanto™ II equipped 
with two lasers (blue 488 nm and red 633 nm lasers), six 
fluorescence channels, and two channels for Forward 
Scatter and Side Scatter. At least 10,000 gated events 
were acquired on a log fluorescence scale. After viable 
and singlet cells were gated, MSCs were first isolated by 
their positivity for CD90, then by positivity for CD73 and 
CD105, and were ultimately identified by their negativity 
for all hematopoietic markers and HLA-DR.
Bioenergetic profiling
Stress tests were completed using the Seahorse Biosci-
ence XFe96 Flux analyzer according to the manufac-
turer’s instructions to measure oxygen consumption 
(mitochondrial stress test) and extracellular acidification 
(glycolysis stress test). The reagents used for the mito-
chondrial stress tests were optimized for maximal effect 
for ASCs isolated from each peri-organ region, and all 
chemicals were obtained from Seahorse Biosciences 
or Sigma Aldrich. Cells from passages 3–9 were seeded 
into 96-well plates at their previously optimized density 
of 40,000 cells per well and allowed to adhere overnight. 
Prior to running the mitochondrial or glycolysis stress 
assays, cells were first washed with assay media contain-
ing 3  mM l-glutamine, 1  mM pyruvate and 8  mM glu-
cose, and incubated at 37 °C in a non-CO2 environment 
60 min prior to the Seahorse assay in order to allow the 
cells to become equilibrated with the assay medium. The 
XFe96 sensor cartridge was pre-hydrated with calibrant 
solution overnight at room temperature prior to the 
experimental assay.
Oxygen consumption rates (OCR) were measured in 
the presence of oxidative phosphorylation (OXPHOS) 
driving substrates. After three basal measurements, three 
measurements each were taken after the subsequent 
addition of oligomycin, FCCP (carbonyl cyanide-4-tri-
fluoromethoxyphenylhydrazone), and rotenone/anti-
mycin A combination. These injected drugs block ATP 
synthase, uncouple the oxygen consumption from ATP 
synthesis, and block mitochondrial complexes I and III, 
respectively. For the glycolysis stress test, drugs were 
similarly optimized for each cell type and injected in the 
following order: glucose, oligomycin, and 2-DG (2-deoxy-
d-glucose; glycolysis inhibitor).
Mitochondrial stress test calculations
The basal respiration was recorded as the basal OCR 
minus non-mitochondrial OCR. Following inhibition of 
ATP synthase by oligomycin, ATP production was cal-
culated by subtracting the proton leak from basal res-
piration. Proton leak was defined as remaining basal 
respiration not coupled to ATP production. After injec-
tion of the uncoupler FCCP, maximal respiration was 
calculated by subtracting the non-mitochondrial respira-
tion from the highest OCR value obtained. The respira-
tory control ratio (RCR) was then calculated by dividing 
maximal respiration (state 3u) by proton leak (state 4o). 
Coupling efficiency was calculated as a percentage by 
dividing ATP production by basal respiration and multi-
plying the final value by 100.
Glycolysis stress test calculations
Glycolysis was defined as the extracellular acidifica-
tion rate (ECAR) due to the utilization of exogenously 
provided glucose. After addition of glucose, glycolysis 
was calculated by subtracting non-glycolytic acidifica-
tion (NGA) ECAR with the highest ECAR value, where 
NGA was extracellular acidification not due to utiliza-
tion of exogenous glucose. Following injection of oligo-
mycin, glycolytic capacity was calculated as the basal 
ECAR subtracted from the highest ECAR used to meet 
cellular demands after ATP synthase is inhibited. Gly-
colytic reserve is calculated as a percentage by dividing 
glycolytic capacity with glycolysis, and multiplying by 
100.
Table 1 Antibodies used for flow cytometry analysis
Tube Antibody Flourochrome Purpose
1 Mouse anti-human CD90 FITC Compensation
2 Mouse anti-human CD44 PE Compensation
3 Mouse anti-human CD105 PerCP Compensation
4 Mouse anti-human CD73 APC Compensation
5 hMSC positive cocktail and hMSC negative 
cocktail
FITC (CD90), PerCP (CD015), APC (CD73), PE 
(CD34, CD11B, CD19, CD45, HLA-DR)
Evaluation of positive and negative MSC 
markers
6 Unstained NA Control
7 hMSC positive isotype control and PE hMSC 
negative isotype control
FITC (CD90), PerCP (CD015), APC (CD73), PE 
(CD34, CD11B, CD19, CD45, HLA-DR)
Negative staining control
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Statistical analysis
A one-way ANOVA post hoc analysis was conducted to 
compare for significance between each parameter for 
ASCs isolated from different adipose tissue organ loca-
tions. Where there was significance found in the ANOVA 
test for a measured parameter (α = 0.05), a Tukey’s HSD 
test was performed to identify pairwise significance. Sta-
tistics were performed in R, and graphs were created in 
GraphPad Prism 6 (La Jolla, CA).
Results
Flow cytometry
Following the gating of 10,000 viable cells as P1 (Fig. 1a), 
with an n = 3 for each anatomical adipose tissue loca-
tion, doublet discrimination was performed to detect 
disproportions between cell size and cell signal in order 
to insure data collected was not skewed by cell aggre-
gates. For each respective anatomical location, the P1 
population is positive for CD markers 90, 73, and 105. 
Viable and singlet cells were marked for mesenchymal 
(CD90, CD73, and CD105) and hematopoietic markers 
(CD34, CD11B, CD19, and CD45), and HLA-DR. It was 
found that within this parent population that the major-
ity of cells were positive for MSC markers CD90, CD73, 
and CD105, and negative for HSC markers (Mildmay-
White and Khan 2016). This characterization shows 
that our populations of isolated ASCs are mesenchymal 
stem cells and are negative for hematopoietic cell sur-
face markers. Specific statistical data for each popula-
tion of cells is included in Additional file 1: Table S1.
Bioenergetic profiling
Basal respiration of shoulder-region ASCs had the high-
est OCR when compared to the pericardial, thymic and 
abdominal groups (Fig.  2a). OCR associated with ATP 
production was similar across all groups with no signifi-
cance (Fig. 2b). Proton leak OCR was significantly high-
est in shoulder ASCs compared to abdominal ASCs, and 
there were no significant differences between the other 
groups (Fig.  2c). Maximal respiration OCR was similar 
in all groups (Fig.  2d). Although the respiratory control 
ratio (RCR) was highest in abdominal ASC there were 
no significant differences between experimental groups 
(Fig.  2e). Similarly, there were no significant differences 
in coupling efficiency (CE) between groups (Fig. 2f ).
There were no significant differences in glycolytic ECAR 
between the groups (Fig. 3a). The glycolytic capacity was 
significantly higher in shoulder ASCs than thymic and per-
icardial ASCs (Fig. 3b). There was no were no significant 
differences in glycolytic reserve between groups (Fig. 3c).
Although non-mitochondrial respiration was highest in 
knee ASCs, there were no significant differences between 
Fig. 1 Flow cytometry characterization of isolated ASCs. Representative gating of P1 and singlet populations (a), and flow cytometry analysis for 
ASCs isolated from pericardium (b), thymus (c), shoulder (d), abdomen (e), and knee (f) (n = 3 for each location). The histogram for each tissue type 
depicts the negative lineage hematopoietic markers. For each respective anatomical location, the P1 population is positive for CD markers 90, 73, 
and 105. The histogram for each tissue type shows the negative lineage hematopoietic markers and HLA-DR, with the bars defined based on an 
unstained and isotype control. This characterization shows that the populations of isolated ASCs contain a majority of mesenchymal stem cells with 
limited contamination by hematopoietic cells
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the groups (Fig.  4a). ECAR for non-glycolytic acidifica-
tion was significantly lower in abdominal ASCs com-
pared to knee and shoulder ASCs (Fig. 4b).
Discussion
The emerging field of regenerative medicine has iden-
tified  adipose  tissue as an abundant source of  stem/
stromal  cells  for tissue engineering applications. Due 
to its mesodermal origin, ASCs can differentiate into 
adipose lineage cells (Zuk et  al. 2001), osteogenic cells 
(Gimble et  al. 2011), chondrogenic cells (Ogawa et  al. 
2004) and myogenic cells (Bacou et  al. 2004), making 
ASCs ideal for tissue repair and regeneration. In the pre-
sent study, a basic flow cytometry panel was performed 
Fig. 2 Mitochondrial stress test calculations. Values from each group of ASCs were averaged and then graphed together under the respective cal-
culations made for: a basal respiration, b ATP production, c proton leak, d maximal respiration, e respiratory control ratio, and f coupling efficiency. 
Oxygen consumption rates (OCR) of shoulder ASCs were significantly higher than other ASC groups for both basal respiration and proton leak. 
Graphs are presented as mean ± SEM, with n = 4 for all organ specific adipose tissue types
Fig. 3 Glycolysis stress test calculations. Values from each group of ASCs were averaged and then graphed together under the respective calcula-
tions made for: a glycolysis, b glycolytic capacity, and c glycolytic reserve. Extracellular acidification rates (ECAR) of shoulder ASCs were significantly 
higher than other ASC groups for glycolytic capacity. Graphs are presented as mean ± SEM, with n = 4 for all organ specific adipose tissue types
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to confirm that a majority of cells isolated were positive 
for mesenchymal stem cell markers CD90, CD73, and 
CD105 (Fig. 1) and negative for hematopoietic markers, 
thereby supporting identification of ASCs despite ana-
tomic location. Interestingly in previous research, ASCs 
isolated from subcutaneous tissue have been shown to 
demonstrate enhanced adipogenic differentiation capac-
ity relative to ASCs derived from other areas (Russo et al. 
2014). Numerous factors may contribute to the differen-
tiation proficiency in these cells, including differences in 
reserve capacity as discussed below, changes in mtDNA 
(Hämäläinen 2016) or metabolic reconfiguration (Forni 
et al. 2016).
Extrapolating from this concept, we compared 
the  bioenergetic profiles of  adipose-derived  stem/stro-
mal  cells  isolated from five different subcutaneous  adi-
pose  sites.  The vascularization of tissues at different 
anatomical locations may affect and alter the cellular 
milieu and surrounding microenvironment, resulting in 
bioenergetic differences dependent on donor physiology. 
Indeed in both humans (Russo et  al. 2014) and animals 
(Via et  al. 2012; Rolfe and Brand 1997) there is adipose 
depot-dependent and donor-dependent variability that 
alters cell yield, viability, immunophenotype, doubling 
time, differentiation capacities, and metabolic differ-
ences. Overall, shoulder ASCs had the highest basal res-
piration, proton leak and glycolytic capacity. To discuss 
these parameters, basal respiration is defined as the oxy-
gen consumed that is used to meet cellular ATP demand. 
Basal respiration is strongly controlled by ATP turnover, 
and partly by substrate oxidation and proton leak (Brand 
and Nicholls 2011). Proton leak refers to the remaining 
basal respiration not coupled to ATP production, and 
finally, glycolytic capacity refers to the part of ECAR used 
to meet cellular demands when ATP synthesis has been 
inhibited by oligomycin.
Conceptually, isolated mitochondria can reach the res-
piratory state 4o when ATP synthase is inhibited by oli-
gomycin, stopping proton re-entry through the synthase 
and slowing respiration. Respiration is then strongly con-
trolled by proton leak kinetics and partially by substrate 
oxidation in state 4o, making respiration responsive to 
dysfunction caused by uncoupling, relatively insensitive 
to changes in substrate oxidation, and completely insen-
sitive to changes in ATP turnover (Brand and Nicholls 
2011; Masini et al. 1983). State 4, which is similar to state 
4o but with a contributing factor of ATP recycling, is sen-
sitive to changes in both proton leak and ATP turnover 
(Divakaruni and Brand 2011). In these hypothetical states 
where the mitochondria are isolated, a large increase in 
proton leak would indicate that mitochondria are severely 
damaged due to uncoupling. In uncoupled states, there is 
also a propensity to have increased production of reac-
tive oxygen species (ROS) and thereby increased tissue 
damage. However, proton leak is not merely an artifact of 
isolated mitochondria; it is also observed in intact cells. 
Indeed, proton leak can account for a large percentage 
of oxygen consumption in resting cells (Rolfe and Brand 
1997; Divakaruni and Brand 2011; Krauss et  al. 2002), 
though it should be noted that the proton leak data in 
the current experiment is unavoidably elevated since 
the addition of oligomycin inhibits phosphorylation and 
subsequently increases proton leak. In  vivo, standard 
metabolic rate can vary between different major oxygen-
consuming tissues. Cardiac tissue can have a low proton 
leak, whereas liver and skeletal muscle will have moder-
ate and high proton leaks, respectively (Rolfe and Brand 
1997; Rolfe and Brown 1997; Rolfe et al. 1999). Therefore, 
Fig. 4 Non-mitochondrial respiration and non-glycolytic acidification calculations. No differences were appreciated in oxygen consumption rates 
(OCR) calculated for non-mitochondrial respiration (a). Abdominal extracellular acidification rates (ECAR) rates were lowest for ASCs under non-
glycolytic acidification (b). Graphs are presented as mean ± SEM, with n = 4 for all organ specific adipose tissue types
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it might be expected that ASCs isolated from an area near 
skeletal muscle would have a higher proton leak value, 
since the ASCs within the shoulder adipose tissue con-
tribute to healing and repair of shoulder muscles. Indeed 
in a rotator cuff model using ASCs, the adipose tissue 
and increased fatty infiltration of the muscle resulted in 
better healing and regeneration (Oh et al. 2014). Moreo-
ver, ASCs derived from rotator cuff regions have greater 
myogenic potential than bone marrow derived mesen-
chymal stem cells (Tsai et al. 2013; Valencia Mora et al. 
2015). Since cellular ATP demand is also greater in skele-
tal muscle, it is logical for shoulder ASCs to have a higher 
basal respiration. Additionally, white adipose tissue can 
be classified into three major types based on stromal con-
tent, vascularity, and adipocyte morphology. Adipose tis-
sue located in specific areas, including the shoulder, has 
been found to have moderate stroma and significant vas-
cularization as compared to other types of white adipose 
tissue (Sbarbati et al. 2010). The increased vascular com-
ponent supports the increased metabolic activity of ASCs 
residing in the shoulder.
In line with this logic, subcutaneous abdominal ASCs 
are isolated from a region that does not require fast cell 
turnover and cells that support an increased bioenergetic 
state, unlike ASCs from omental adipose tissue (Russo 
et al. 2014; Shah et al. 2014). In the present experiment, 
the ECAR of abdominal ASCs was found to be lowest of 
all groups under non-glycolytic acidification. Moreover, 
the higher glycolytic capacity observed in shoulder ASCs 
can be explained by the higher ECAR necessary to meet 
the cellular demands associated with increased basal res-
piration and proton leak.
In our studies we also estimated the coupling efficiency 
(CE) and the respiratory control ratio (RCR), of the iso-
lated ASCs. CE is calculated as the proportion of mito-
chondrial respiratory rate used to drive ATP synthesis 
(i.e., perfectly coupled OXPHOS will have a CE = 100%, 
while a pure state 4 respiration will have CE = 0%) (Diva-
karuni and Brand 2011). RCR is calculated as a ratio 
between the cellular proton leak and their maximal 
capacity. Therefore, a change in either one of these two 
parameters will alter RCR, offering a solid estimation of 
overall bioenergetic dysfunction. Since CE and RCR are 
calculated as ratios, both measures are useful internal 
controls. However, the CE and RCR did not significantly 
differ between ASCs from each location in this study. The 
fact that we observed no significant differences in CE and 
RCR between groups could be explained by biomechan-
ics and organ function. Due to the constant, but nor-
mal, wear and tear of pressures imposed upon the knee 
joints during ambulation, the cells in that peri-organ 
region require a faster rate of healing, proliferation, and 
regeneration. Similarly, the function of human heart 
requires the peri-organ milieu to support quick cell turn-
over, proliferation and regeneration. Furthermore, due to 
the high oxygen demand of cardiac cells required to sus-
tain diastolic and systolic contractions, it is logical that 
pericardial ASCs would display a maximal respiration 
state compared to ASCs from skeletal muscle regions 
(e.g., shoulder).
Conclusions
In summary, our data suggest that ASC utility is bioen-
ergetically independent of anatomical adipose tissue 
harvest site. However, it is still likely that bioenergetic 
differences will vary depending on the individual “stem 
cell niche”, which describes the physiological microen-
vironment that supports stem cells in specific anatomic 
locations and regulates how stem cells participate in tis-
sue generation, maintenance and repair (Via et al. 2012). 
Therefore, while subcutaneous ASC utility may be overall 
independent of the anatomical harvest site (Choudhery 
et  al. 2015), the bioenergetic profile of ASCs from adi-
pose tissue of various peri-organ regions will be reflected 
by its respective physiological functions, niche and 
microenvironment.
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